Aberrant type 1 immunity drives susceptibility to mucosal fungal infections

Male T-Lymphocytes Mice Receptors Candida albicans Medicine and Health Sciences 2.1 Biological and endogenous factors Aetiology Polyendocrinopathies, Autoimmune Immunologic Surveillance Inbred BALB C Mucosal Mice, Inbred BALB C 0303 health sciences Interleukin-17 Candidiasis, Chronic Mucocutaneous Candidiasis Life Sciences Middle Aged 3. Good health Infectious Diseases STAT1 Transcription Factor Female Infection Genomics and Computational Biology Core Adult Adolescent General Science & Technology 610 Chronic Mucocutaneous Autoimmune Disease Young Adult Interferon-gamma 03 medical and health sciences Animals Humans Immunity, Mucosal JMG Aged Janus Kinases Animal Inflammatory and immune system Interleukins Immunity Mouth Mucosa Disease Models, Animal Emerging Infectious Diseases Polyendocrinopathies Disease Models Autoimmune
DOI: 10.1126/science.aay5731 Publication Date: 2021-01-14T20:06:30Z
ABSTRACT
Type 1 immunity gives fungi a foothold Type 17 immune responses play a vital role against fungal infections of the mucosa. It remains unclear whether other types of immune responses can also contribute to host defense against these pathogens. The yeast Candida albicans prominently infects patients with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED), an inherited disease caused by loss-of-function mutations in the AIRE gene. Break et al. report that the oral susceptibility of Aire -deficient mice to C. albicans is not due to aberrant type 17 responses. Rather, the overproduction of interferon-γ by local CD4 + and CD8 + T cells in these mice disrupts the epithelial barrier, which increases susceptibility to C. albicans invasion. Similar type 1 immune pathways are operational in APECED patients. Inhibition of interferon-γ or the JAK-STAT signaling pathway in mice ameliorates disease symptoms, suggesting potential future therapeutic interventions for certain classes of fungal disease. Science , this issue p. eaay5731
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (74)
CITATIONS (123)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....